Zhehui Zhu - Publications

YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.

Journal: Cell death and differentiation

Published: June 28, 2024

Endpoint-aware audio-visual speech enhancement utilizing dynamic weight modulation based on SNR estimation.

Journal: Neural networks : the official journal of the International Neural Network Society

Published: April 06, 2024

Precision medicine in the treatment of colorectal cancer with liver metastases.

Journal: Cancer biology & medicine

Published: February 06, 2024

ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 24, 2023

Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 07, 2023

ELK4 exerts opposite roles in cytokine/chemokine production and degranulation in activated mast cells.

Journal: Frontiers in immunology

Published: February 22, 2023

LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: September 23, 2022

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.

Journal: Nature communications

Published: June 30, 2021

Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer.

Journal: Frontiers in oncology

Published: January 22, 2021

Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 29, 2020

Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D3 in colorectal cancer.

Journal: Theranostics

Published: January 17, 2020

LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Journal: Oncogene

Published: November 25, 2019